1.47 (-%)
As of Nov 21, 2024
Source:
Actinium Pharmaceuticals, Inc. is a biopharmaceutical company developing targeted radiotherapies to deliver cancer-killing radiation with cellular level precision to treat patients with highunmet medical needs. Our vision is to build a specialty, hospital focused radiotherapeutics company that develops and markets medicinesfor relapsed or refractory cancer patients who are treated primarily in large quaternary care hospitals and their catchment areas.
Country | United States |
Headquarters | new york, new york |
Phone Number | (646) 677-3870 |
Industry | manufacturing |
CEO | Sandesh Seth |
Website | www.actiniumpharma.com |